Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Brief Summary: This is a Phase 3, randomized, placebo-controlled, double-blind,double-dummy, parallel-group, 12-week study in male and female patients, 12 years of age and older, with persistent asthma.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: FlutiForm 250/10 | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: SKP-Fluticasone | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: Flovent Fluticasone HFA | Intervention Type: DRUG; Name: FlutiForm 250/10; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: SKP-Fluticasone; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Flovent Fluticasone HFA; Assigned to Arm(s): 3
B: Arm Label: BDP 320 mcg BAI; Type: EXPERIMENTAL; Interventions: Drug: Beclomethasone dipropionate, Drug: Placebo, Drug: Albuterol/salbutamol | Arm Label: BDP 640 mcg BAI; Type: EXPERIMENTAL; Interventions: Drug: Beclomethasone dipropionate, Drug: Placebo, Drug: Albuterol/salbutamol | Arm Label: BDP 320 mcg MDI; Type: ACTIVE_COMPARATOR; Interventions: Drug: Beclomethasone dipropionate, Drug: Placebo, Drug: Albuterol/salbutamol | Arm Label: BDP 640 mcg MDI; Type: ACTIVE_COMPARATOR; Interventions: Drug: Beclomethasone dipropionate, Drug: Placebo, Drug: Albuterol/salbutamol | Arm Label: Placebo BAI and MDI; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Albuterol/salbutamol | Intervention Type: DRUG; Name: Beclomethasone dipropionate; Assigned to Arm(s): BDP 320 mcg BAI, BDP 320 mcg MDI, BDP 640 mcg BAI, BDP 640 mcg MDI | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): BDP 320 mcg BAI, BDP 320 mcg MDI, BDP 640 mcg BAI, BDP 640 mcg MDI, Placebo BAI and MDI | Intervention Type: DRUG; Name: Albuterol/salbutamol; Assigned to Arm(s): BDP 320 mcg BAI, BDP 320 mcg MDI, BDP 640 mcg BAI, BDP 640 mcg MDI, Placebo BAI and MDI
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: budesonide/formoterol | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: budesonide and placebo | Intervention Type: DRUG; Name: budesonide/formoterol; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: budesonide and placebo; Assigned to Arm(s): 2
D: Arm Label: MF/F MDI 400/10 mcg BID; Type: EXPERIMENTAL; Interventions: Drug: Mometasone furoate/formoterol (MF/F) combination | Arm Label: MF/F MDI 200/10 mcg BID; Type: EXPERIMENTAL; Interventions: Drug: Mometasone furoate/formoterol (MF/F) combination | Arm Label: MF MDI 400 mcg BID; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mometasone furoate MDI (MF MDI) | Intervention Type: DRUG; Name: Mometasone furoate/formoterol (MF/F) combination; Assigned to Arm(s): MF/F MDI 400/10 mcg BID | Intervention Type: DRUG; Name: Mometasone furoate/formoterol (MF/F) combination; Assigned to Arm(s): MF/F MDI 200/10 mcg BID | Intervention Type: DRUG; Name: Mometasone furoate MDI (MF MDI); Assigned to Arm(s): MF MDI 400 mcg BID

Answer: B